China Universal Asset Management Company’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $119K | Buy |
34,434
+431
| +1% | +$1.49K | 0.01% | 349 |
|
2025
Q1 | $89.1K | Sell |
34,003
-1,488
| -4% | -$3.9K | 0.01% | 364 |
|
2024
Q4 | $146K | Buy |
35,491
+9,740
| +38% | +$40.1K | 0.01% | 355 |
|
2024
Q3 | $182K | Buy |
25,751
+10,157
| +65% | +$71.9K | 0.02% | 310 |
|
2024
Q2 | $102K | Sell |
15,594
-9,616
| -38% | -$62.7K | 0.01% | 301 |
|
2024
Q1 | $209K | Buy |
25,210
+10,953
| +77% | +$90.9K | 0.03% | 283 |
|
2023
Q4 | $157K | Buy |
14,257
+11,122
| +355% | +$122K | 0.03% | 229 |
|
2023
Q3 | $26.4K | Buy |
3,135
+1,541
| +97% | +$13K | 0.01% | 281 |
|
2023
Q2 | $20K | Sell |
1,594
-50
| -3% | -$628 | 0.01% | 268 |
|
2023
Q1 | $27.1K | Buy |
1,644
+416
| +34% | +$6.85K | 0.01% | 192 |
|
2022
Q4 | $18.3K | Buy |
1,228
+208
| +20% | +$3.11K | 0.01% | 181 |
|
2022
Q3 | $23K | Buy |
+1,020
| New | +$23K | 0.01% | 148 |
|